32. Zhou B, Honor LB, He H, Ma Q, Oh JH, et al. (2011) Adult mouse epicardium modulates myocardial injury by secreting paracrine factors. J Clin Invest 121: 1894–1904. 33. Wagner KD, Wagner N, Bondke A, Nafz B, Flemming B, et al. (2002) The Wilms’ tumor suppressor Wt1 is expressed in the coronary vasculature after myocardial infarction. FASEB J 16: 1117–1119. 34. Rudat C, Kispert A (2012) Wt1 and Epicardial Fate Mapping. Circ Res 111: 165–169. 35. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, et al (2007) Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13: 952–961. 36. Aisagbonhi O, Rai M, Ryzhov S, Atria N, Feoktistov I, et al. (2011) Experimental myocardial infarction triggers canonical Wnt signaling and endothelial-to-mesenchymal transition. Dis Model Mech 4: 469–483. 37. van Amerongen MJ, Bou-Gharios G, Popa E, van Ark J, Petersen AH, et al. (2008) Bone marrow-derived myofibroblasts contribute functionally to scar formation after myocardial infarction. J Pathol 214: 377–386. 38. Soonpaa MH, Field LJ (1997) Assessment of cardiomyocyte dna synthesis in normal and injured adult mouse hearts. Heart Cir 41: H220–H226. 39. Martinez-Estrada OM, Lettice LA, Essafi A, Guadix JA, Slight J, et al. (2010) Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin. Nat Genet 42: 89–93. 40. Bornstein P (2000) Matricellular proteins: an overview. Matrix Biol 19: 555–556. 41. Yang Z, Kyriakides TR, Bornstein P (2000) Matricellular proteins as modulators of cell-matrix interactions: adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matrix metalloproteinase-2. Mol Biol Cell 11: 3353–3364. 42. Duan J, Gherghe C, Liu D, Hamlett E, Srikantha L, et al, (2012) Wnt1/ betacatenin injury response activates the epicardium and cardiac fibroblasts to promote cardiac repair. EMBO J 31: 429–442. 43. Buermans HP, van Wijk B, Hulsker MA, Smit NC, den Dunnen JT, et al. (2010) Comprehensive gene-expression survey identifies wif1 as a modulator of cardiomyocyte differentiation. PLoS ONE 5: e15504. 44. van Wijk B, Moorman AFM, van den Hoff MJB (2007) Role of bone morphogenetic proteins in cardiac differentiation. Cardiovasc Res 74: 244–255. 45. Poss KD, Wilson LG, Keating MT (2002) Heart regeneration in zebrafish. Science 298: 2188–2190. 46. Wessels A, Perez-Pomares JM (2004) The epicardium and epicardially derived cells (EPDCs) as cardiac stem cells. Anat Rec 276A: 43–57. 47. Urbanek K, Cesselli D, Rota M, Nascimbene A, De Angelis A, et al. (2006) Stem cell niches in the adult mouse heart. Proc Natl Acad Sci U S A 103: 9226–9231. 48. Hsieh PC, Segers VF, Davis ME, MacGillivray C, Gannon J, et al. (2007) Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med 13: 970–974. 49. Red-Horse K, Ueno H, Weissman IL, Krasnow MA (2010) Coronary arteries form by developmental reprogramming of venous cells. Nature 464: 549–553. Endogenous Epicardial Regenerative Response 50. Munoz-Chapuli R, Gonzalez-Iriarte M, Carmona R, Atencia G, Macias D, et al. (2002) Cellular precursors of the coronary arteries. Tex Heart Inst J 29: 243– 249. 51. Perez-Pomares JM, Gonzalez-Rosa JM, Munoz-Chapuli R (2009) Building the vertebrate heart - an evolutionary approach to cardiac development. Int J Dev Biol 53: 1427–1443. 52. Manner J (1999) Does the subepicardial mesenchyme contribute myocardio- blasts to the myocardium of the chick embryo heart? A quail-chick chimera study tracing the fate of of the epicardial primordium. Anat Rec 255: 212–226. 53. Song YH, Pinkernell K, Alt E (2011) Stem cell induced cardiac regeneration: Fusion/mitochondrial exchange and/or transdifferentiation? Cell Cycle 10: 2281–2286. 54. Rose BA, Force T, Wang Y (2010) Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev 90: 1507– 1546. 55. Geng Y, Dong Y, Yu M, Zhang L, Yan X, et al. (2011) Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development. Proc Natl Acad Sci U S A 108: 7058–7063. 56. Sylva M, Li VS, Buffing AA, van Es JH, van den Born M, et al. (2011) The BMP antagonist follistatin-like 1 is required for skeletal and lung organogenesis. PLoS ONE 6: e22616. 57. Tanaka M, Murakami K, Ozaki S, Imura Y, Tong XP, et al. (2010) DIP2 disco- interacting protein 2 homolog A (Drosophila) is a candidate receptor for follistatin-related protein/follistatin-like 1–analysis of their binding with TGF- beta superfamily proteins. FEBS J 277: 4278–4289. 58. Oshima Y, Ouchi N, Sato K, Izumiya Y, Pimentel DR, et al. (2008) Follistatin- like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart. Circulation 117: 3099–3108. 59. Ouchi N, Oshima Y, Ohashi K, Higuchi A, Ikegami C, et al. (2008) Follistatin- like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism. J Biol Chem 283: 32802–32811. 60. Scheinowitz M, Abramov D, Eldar M (1997) The role of insulin-like and basic fibroblast growth factors on ischemic and infarcted myocardium: a mini review. Int J Cardiol 59: 1–5. 61. Markwald RR, Norris RA, Moreno-Rodriguez R, Levine RA (2010) Developmental basis of adult cardiovascular diseases: valvular heart diseases. Ann N Y Acad Sci 1188: 177–183. 62. Norris RA, Moreno-Rodriguez R, Hoffman S, Markwald RR (2009) The many facets of the matricelluar protein periostin during cardiac development, remodeling, and pathophysiology. J Cell Commun Signal 3: 275–286. 63. Oka T, Xu J, Kaiser RA, Melendez J, Hambleton M, et al. (2007) Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res 101: 313–321. PLOS ONE | www.plosone.org 14 September 2012 | Volume 7 | Issue 9 | e44692